Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Valuable Targets
6 min read
The Clinical Application of Histamine Receptor Antagonists
21 September 2023
Histamine receptors are proteins found in various tissues throughout the human body.
Drug Insights
4 min read
Estradiol valerate: Detailed Review of its Transformative R&D Success
21 September 2023
This article summarized the latest R&D progress of Estradiol valerate, the Mechanism of Action for Estradiol valerate, and the drug target R&D trends for Estradiol valerate.
Latest Hotspot
3 min read
Heidelberg Pharma Shares Progress Report for Phase I/IIa Clinical Study Involving HDP-101
21 September 2023
Heidelberg Pharma AG announced it began patient recruitment for the fifth group in the Phase I/IIa trial of their main development candidate, HDP-101, with a dose of 100 µg/kg.
Drug Insights
4 min read
Diazoxide Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
21 September 2023
This article summarized the latest R&D progress of Diazoxide, the Mechanism of Action for Diazoxide, and the drug target R&D trends for Diazoxide.
Valuable Targets
4 min read
Progress in the Research of Heparin antagonists
21 September 2023
Heparin is a naturally occurring anticoagulant that plays a crucial role in the human body's blood clotting process.
Drug Insights
4 min read
Unleashing the Power of Brompheniramine maleate: A Comprehensive Review on R&D Breakthroughs
21 September 2023
This article summarized the latest R&D progress of Brompheniramine maleate, the Mechanism of Action for Brompheniramine maleate, and the drug target R&D trends for Brompheniramine maleate.
Latest Hotspot
3 min read
Orexo submits NDA for OX124 to FDA, a high-potency antidote for opioid overdose
21 September 2023
Orexo AB recently submitted its NDA to the US FDA for OX124, a high-dose, nasally-administered treatment for opioid overdoses.
Drug Insights
4 min read
A Comprehensive Review of Lomustine's R&D Innovations and Drug Target Mechanism
21 September 2023
This article summarized the latest R&D progress of Lomustine, the Mechanism of Action for Lomustine, and the drug target R&D trends for Lomustine.
Advanced Tech.
7 min read
Medications intervening from the root of difficult and complex diseases: Oligonucleotides
21 September 2023
Oligonucleotides (ONs) are a class of drugs composed of single or double strands of oligonucleotides synthesized by artificial chemistry.
Drug Insights
5 min read
Pharmaceutical Insights: Vorinostat's R&D Progress and its Mechanism of Action on Drug Target
21 September 2023
This article summarized the latest R&D progress of Vorinostat, the Mechanism of Action for Vorinostat, and the drug target R&D trends for Vorinostat.
Latest Hotspot
3 min read
Yescarta® Car T-cell therapy from Kite greatly boosts treatment response and prolongs remission in relapsed/resistant Large B-cell Lymphoma patients
21 September 2023
Kite's Car T-cell Therapy Yescarta® exhibits a substantial treatment response rate and durable remission for patients with relapsed/resistant Large B-cell Lymphoma.
Drug Insights
4 min read
Exploring Voclosporin's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
21 September 2023
This article summarized the latest R&D progress of Voclosporin, the Mechanism of Action for Voclosporin, and the drug target R&D trends for Voclosporin.